One global service provider- is it really providing services to the globe?

I have searched for this company in many platforms but couldn’t find much information. so starting a thread here to get insights from our value pickr fellow members.

Company name- One global service provider( previously overseas synthetic limited)
Market Cap- 214 Crores

Introduction

A leading provider in the field of Life Sciences and Healthcare Solutions across the globe. We have the expertise in mass screening, diagnostics and healthcare sciences which are used by eminent hospitals, healthcare professionals and government bodies.

Having a vast array of healthcare services, we provide a multitude of services that ensure the best laboratory reports and diagnosis. With a state-of-the-art laboratory equipment, our experienced laboratory professionals and pathologists, we ensure quality reports which are at par with International Standards.

We have established U.A.E. as the most innovative healthcare system on the global map of healthcare and thus bring affordable healthcare within every citizen’s reach across the U.A.E.

In today’s new era of digital healthcare, we partner with the best by providing a single online platform with healthcare products ranging from medical devices, equipment’s to medical consumables and reagents. It’s our trusted results that offer all clients - “A One-Stop Solution” to receiving the best possible services under one roof by offering an easy access to quality healthcare products.

We believe, there are all kinds of right but the right to health is one of the most imperative. Anthis compels us to bring world class health services and products to your doorstep. Accuracy, Affordability and Accessability in our DNA makes us health-centric.

VISION AND MISSION

:heavy_check_mark: To make quality healthcare services and products
available to all citizens across the globe and reduce per
capita medical expenditure using innovative health
technology. To help businesses in transforming and
succeeding through technological advances and never we
left behind in the fast changing times.
:heavy_check_mark: The Code of our belief is Diagnosis is not just a process; it
is an intermediary link between health specialists and
patients that alters the condition of illness to wellness
and survival to prevention.
:heavy_check_mark: To be at toes with the changing times and provide
solutions and deliver the best-in-class services to its
clients.

Healthcare Services provided by the company

Laboratory services
Microbology
Haemology & Coagulation
Clinical pathology
Molecular diagnostics
Serology

Diagnostic Services

Anemia profile
Antenatal
Diabetes/Hypertension/Kidne/Liver/Lipid etc

IT services

Provide consultancy and development (requirements, design, develop, test, integrate, deploy, maintain) of software/IT product and its enabled services to all sectors/domain but not limited to e-commerce, transportation, banking, entertainment and gaming industry, education, hospitality, health and wellness, retail, multimedia, telecommunication, network security, web-hosting, bio-technology, e-governance, infrastructure, food, agriculture, engineering, research, marketing and software sectors, using latest technology prevailing in the industry in various programming languages. Ability to digitize working environment comprising of manual and/or semi-automated process steps with a software application.

Purchase, Sell, distribute licenses, resell, import, export IT and/or software products and its enabled services across the globe including India and provide maintenance services as per the need of the customer.

In addition to above mentioned, provide software only solutions around but not limited to data analytics, machine learning, artificial intelligence, statistical inferences, etc.

Provide hardware solution to host software applications developed including Server, router and its related accessories

Management team

Financial performance of the company

Company is showing tremendous QoQ growth and on yearly basis as well

Borrowing is almost nil

Cash flow from operations is also positive

Now let’s come to risk part:

  1. Sales done in H1 2024 was 32.97 crores whereas Trade receivables increased by 8.53 crores as compared to last year, so from collection point of view company is very poor. As of September 2024 company has an O/S debtors of 34.71 crores and has Debtor collection days of 322 days which is very very high for the company in health care sector where normally customers pay in advance.

  2. Low promoter holding which is at 29.51%, this could be due to promoter/management change in 2020.
    https://www.business-standard.com/markets/one-global-service-provider-ltd-share-price-3447.html#goog_rewarded

  3. No noncalls, no investor presentation and never heard about the company or its products in India or in UAE.

One positive point to be noted that recently in H1 2024, FII’s have bought 15.26% shares in the company

Disc- Invested at 180 level & biased.

6 Likes

Anything on the quality of services, customer base business strategy etc? The information given in the post is already available in the public domain.

Laboratories are most revenue make dependent in a hospital after ICU.

BUT, problems are
1.Laboratory service industry is asset heavy model.
2. Expansion are not so successful
3. Doctors referral are upto 30% eats up the margin
4. Quality aren’t standards
5. Unorganised sector operators 60%.

There are successful companies performing good in laboratories but they have got legacy attached

1 Like

I have shared all the information I could gather. As mentioned in the post, there isn’t much information available about the company or its customers and vendors. I have sent them an email asking for an explanation, but I haven’t received a response yet.

I found this on their 24 annual report.

Trade receivables consist of a large number of customers, spread across diverse industries and geographical areas. The Company evaluates the concentration of risk with respect to trade receivables as low, as its customers are located in several jurisdictions and operate in independent markets. Ongoing credit evaluation is performed on the financial condition of accounts receivable and, where appropriate. The average credit period are generally in the range of 14 days to 90 days. Credit limits are established for all customers based on internal rating criteria.

They have formed one risk management committee also as per their 24 annual report.One more observation that company post December quarter result good and it’s logical also because hospital whole sector posts good result so planning to observe one more quarter atleast.

Invested at 175(8%) of my portfolio

Wonderful results declared by the company..
QoQ sales sales increased by 128%, profit increased by 177%, Full YoY sales increased by 133% to Rs 148 crores and profit 144% to Rs 18.5 crores.. Cash generated from operations Rs 14.4 crores..

3a46af8a-0615-4065-a7e1-045bc0e49367.pdf (2.4 MB)

Company is trading at PE of just 9.45 and Price to Sales ratio of 1.1

Inspite of all this, stock price corrected by 50% and have seen continous lower circuits from 3 April to 19 May.. If books are not cooked up then definitely this stock deserves market cap of 700-800 Crores..

One promoter has transferred his shares to trust that is why screener is showing reduction in promoter’s shareholding..
Sanjay Kirpalani- Chairman of the ENPEE Group including RenewSys India Pvt. Ltd has bought 7.7% shares in March quarter..
So much positives could not stop company from being corrected by 50%, Either insiders have information we’re not aware of, or this correction was a trap to scoop up shares from retail investors…

As told earlier in the forum, all my calls/emails went unanswered.. now we have to wait for Annual report for more details.

Disc- Invested & Biased.

1 Like